The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
RETRACTED ARTICLE: A mechanism for the suppression of homologous recombination in G1 cells
Open accessAbstract
DNA repair by homologous recombination is highly suppressed in G1 cells to ensure that mitotic recombination occurs solely between sister chromatids. Although many homologous recombination factors are cell-cycle regulated, the identity of the events that are both necessary and sufficient to suppress recombination in G1 cells is unknown. Here we report that the cell cycle controls the interaction of BRCA1 with PALB2-BRCA2 to constrain BRCA2 function to the S/G2 phases in human cells. We found that the BRCA1-interaction site on PALB2 is targeted by an E3 ubiquitin ligase composed of KEAP1, a PALB2-interacting protein, in complex with cullin-3 (CUL3)-RBX1 (ref. 6). PALB2 ubiquitylation suppresses its interaction with BRCA1 and is counteracted by the deubiquitylase USP11, which is itself under cell cycle control. Restoration of the BRCA1-PALB2 interaction combined with the activation of DNA-end resection is sufficient to induce homologous recombination in G1, as measured by RAD51 recruitment, unscheduled DNA synthesis and a CRISPR-Cas9-based gene-targeting assay. We conclude that the mechanism prohibiting homologous recombination in G1 minimally consists of the suppression of DNA-end resection coupled with a multi-step block of the recruitment of BRCA2 to DNA damage sites that involves the inhibition of BRCA1-PALB2-BRCA2 complex assembly. We speculate that the ability to induce homologous recombination in G1 cells with defined factors could spur the development of gene-targeting applications in non-dividing cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“because it is only readily available in dividing cells [110,111]”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [111]
In the citing paper
“Non-mitotic cells are very inefficient for HDR-based repair, which is the main pathway to correct genetic disorders to date [87, 200].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [200]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mitosis Inhibits DNA Double-Strand Break Repair to Guard Against Telomere Fusions
Orthwein, A., Fradet‐Turcotte, A., Noordermeer, S. M., Canny, M. D., Brun, C. M., Strecker, J., Escribano‐Diaz, C., & Durocher, D. (2014) · Science · doi:10.1126/science.1248024 · Cited by 332
Self-citationRetractedGenome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Bunting, S. F., Callén, E., Wong, N., Chen, H.-T., Polato, F., Gunn, A., Bothmer, A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.012 · Cited by 1,671
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Roy, R., Chun, J., & Powell, S. N. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3181 · Cited by 1,555
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,523
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478
Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle
Rothkamm, K., Krüger, I., Thompson, L. H., & Lübrich, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5706-5715.2003 · Cited by 1,187
Repair of Strand Breaks by Homologous RecombinationPreprint
Jasin, M., & Rothstein, R. J. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012740 · Cited by 929
Escribano‐Diaz, C., Orthwein, A., Fradet‐Turcotte, A., Xing, M., Young, J. T. F., Tkáč, J., Cook, M. A., Rosebrock, A. P., Munro, M., Canny, M. D., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.001 · Cited by 903
Self-citationControl of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2
Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J., & Livingston, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.022 · Cited by 861
Self-citation
Cited by
Sorted by citations
Items 201–300 of 462
Factors forming the BRCA1-A complex orchestrate BRCA1 recruitment to the sites of DNA damage
Her, J., Lee, N. S., Kim, Y., & Kim, H. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw047 · Cited by 43
Slade, L., Biswas, D., Ihionu, F., Hiani, Y. E., Kienesberger, P. C., & Pulinilkunnil, T. (2019) · Biochemical Journal · doi:10.1042/bcj20190596 · Cited by 40
Montenegro, M. F., González-Guerrero, R., Sánchez‐del‐Campo, L., Piñero, A., Cabezas‐Herrera, J., & Rodríguez‐López, J. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-70289-3 · Cited by 40
Pauty, J., Couturier, A. M., Rodrigue, A., Caron, M., Coulombe, Y., Dellaire, G., & Masson, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx011 · Cited by 39
Self-citationPerkail, S., Andricovich, J., Yan, K., & Tzatsos, A. (2020) · Nature Communications · doi:10.1038/s41467-020-16589-8 · Cited by 41
Dwane, L., O’Connor, A. E., Das, S., Moran, B., Mulrane, L., Pinto-Fernández, A., Ward, E., Blümel, A. M., Cavanagh, B., Mooney, B., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0214 · Cited by 39
Werder, R. B., Kaserman, J. E., Packer, M. S., Lindstrom-Vautrin, J., Villacorta-Martín, C., Young, L. E., Aratyn-Schaus, Y., Gregoire, F. M., & Wilson, A. A. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.06.021 · Cited by 38
Spiliotopoulos, A., Ferreras, L. A. B., Densham, R. M., Caulton, S. G., Maddison, B. C., Morris, J. R., Dixon, J. E., Gough, K. C., & Dreveny, I. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004469 · Cited by 39
Kabra, M., Shahi, P. K., Wang, Y., Sinha, D., Spillane, A., Newby, G. A., Saxena, S., Tong, Y., Chang, Y., Abdeen, A. A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci171356 · Cited by 36
Nick-initiated homologous recombination: Protecting the genome, one strand at a time
Vriend, L. E. M., & Krawczyk, P. M. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.12.005 · Cited by 37
Directed evolution of hyperactive integrases for site specific insertion of transgenes
Hew, B. E., Gupta, S., Sato, R., Waller, D. F., Stoytchev, I., Short, J. E., Sharek, L., Tran, C. T., Badran, A. H., & Owens, J. B. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae534 · Cited by 35
Roles of Ubiquitination and SUMOylation in DNA Damage Response
Su, S., Zhang, Y., & Liu, P. (2019) · Current Issues in Molecular Biology · doi:10.21775/cimb.035.059 · Cited by 37
Functional interrogation of non-coding DNA through CRISPR genome editing
Canver, M. C., Bauer, D. E., & Orkin, S. H. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.008 · Cited by 36
Cullin 3, a cellular scripter of the non-proteolytic ubiquitin code
Jerabkova, K., & Sumara, I. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2018.12.007 · Cited by 33
Evaluation of Pharmacodynamic Responses to Cancer Therapeutic Agents Using DNA Damage Markers
Wilsker, D. F., Barrett, A. M., Dull, A. B., Lawrence, S. M., Hollingshead, M. G., Chen, A. P., Kummar, S., Parchment, R. E., Doroshow, J. H., & Kinders, R. J. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2523 · Cited by 33
Pold3is required for genomic stability and telomere integrity in embryonic stem cells and meiosis
Zhou, Z., Wang, L., Ge, F., Gong, P., Wang, H., Wang, F., Chen, L., & Liu, L. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky098 · Cited by 34
Evangelista, F. M., Maglott, A., Stierlé, M., Brino, L., Soutoglou, E., & Tora, L. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201803074 · Cited by 35
Ubiquitin and ubiquitin-like molecules in DNA double strand break repair
Yu, J., Qin, B., & Lou, Z. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-0380-1 · Cited by 35
A genome editing primer for the hematologist
Hoban, M. D., & Bauer, D. E. (2016) · Blood · doi:10.1182/blood-2016-01-678151 · Cited by 32
Tamberg, N., Tahk, S., Koit, S., Kristjuhan, K., Kasvandik, S., Kristjuhan, A., & Ilves, I. (2018) · Scientific Reports · doi:10.1038/s41598-018-30562-y · Cited by 32
CSB interacts with BRCA1 in late S/G2 to promote MRN- and CtIP-mediated DNA end resection
Batenburg, N. L., Walker, J. R., Coulombe, Y., Sherker, A., Masson, J., & Zhu, X. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz784 · Cited by 33
Self-citationMitrentsi, I., Lou, J., Kerjouan, A., Verigos, J., Reina‐San‐Martin, B., Hinde, E., & Soutoglou, E. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.033 · Cited by 33
Morris, J. R., & Garvin, A. J. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.05.012 · Cited by 32
van de Kooij, B., van der Wal, F. J., Rother, M. B., Wiegant, W. W., Creixell, P., Stout, M., Joughin, B. A., Vornberger, J., Altmeyer, M., van Vugt, M. A. T. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51090-6 · Cited by 31
Disruptive Technology: CRISPR/Cas-Based Tools and Approaches
Patsali, P., Kleanthous, M., & Lederer, C. W. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00391-4 · Cited by 31
Ackerson, S. M., Romney, C. V., Schuck, P. L., & Stewart, J. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.708763 · Cited by 39
POGZ promotes homology‐directed DNA repair in an HP1‐dependent manner
Heath, J., Simo‐Cheyou, E. R., Findlay, S., Luo, V. M., Carpio, E. P., Lee, J., Djerir, B., Chen, X., Morin, T., Lebeau, B., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051041 · Cited by 33
Self-citationUSP11 mediates repair of DNA–protein cross-links by deubiquitinating SPRTN metalloprotease
Perry, M. C., Biegert, M., Kollala, S. S., Mallard, H. J., Su, G., Kodavati, M. M., Kreiling, N. F., Holbrook, A., & Ghosal, G. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100396 · Cited by 30
Modulating CRISPR/Cas9 genome-editing activity by small molecules
Chen, S., Chen, D., Liu, B., & Haisma, H. J. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.018 · Cited by 32
Bakr, A., Köcher, S., Volquardsen, J., Petersen, C., Borgmann, K., Dikomey, E., Rothkamm, K., & Mansour, W. Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11023 · Cited by 35
Defects in homologous recombination repair behind the human diseases: FA and HBOC
Katsuki, Y., & Takata, M. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0221 · Cited by 32
Bungsy, M., Palmer, M. C. L., Jeusset, L. M., Neudorf, N. M., Lichtensztejn, Z., Nachtigal, M. W., & McManus, K. J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.051 · Cited by 34
Sofianidi, A. A., Dumbrava, E. E. I., Syrigos, K. N., & Nasrazadani, A. (2024) · Cancers · doi:10.3390/cancers16061139 · Cited by 31
CRISPR Craze to Transform Cardiac Biology
van Kampen, S. J., & van Rooij, E. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.06.008 · Cited by 30
Nardi, I. K., Stark, J. M., Larsen, A. B., Salgia, R., & Raz, D. J. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0053 · Cited by 28
Knatko, E. V., Higgins, M., Fahey, J. W., & Dinkova‐Kostova, A. T. (2016) · Scientific Reports · doi:10.1038/srep25804 · Cited by 28
Inhibition of RIF1 by SCAI Allows BRCA1-Mediated Repair
Isobe, S.-Y., Nagao, K., Nozaki, N., Kimurâ, H., & Obuse, C. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.056 · Cited by 31
RPA shields inherited DNA lesions for post-mitotic DNA synthesis
Lezaja, A., Παναγόπουλος, Α., Wen, Y., Carvalho, E., Imhof, R., & Altmeyer, M. (2021) · Nature Communications · doi:10.1038/s41467-021-23806-5 · Cited by 32
Østvold, A. C., Grundt, K., & Wiese, C. (2022) · Biochemical Journal · doi:10.1042/bcj20220075 · Cited by 28
The Role of DNA Damage and Repair in Idiopathic Pulmonary Fibrosis
Zhu, J., Liu, L., Ma, X., Cao, X., Chen, Y., Qu, X., Ji, M. H., Liu, H., Liu, C., Qin, X., et al. (2022) · Antioxidants · doi:10.3390/antiox11112292 · Cited by 29
Ubiquitin signaling and the proteasome drive human DNA–protein crosslink repair
Essawy, M. M., Chesner, L. N., Alshareef, D., Ji, S., Tretyakova, N. Y., & Campbell, C. J. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad860 · Cited by 27
Regulation of XPC deubiquitination by USP11 in repair of UV-induced DNA damage
Shah, P., Qiang, L., Yang, S., Soltani, K., & He, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.22105 · Cited by 27
Beyond classic editing: innovative CRISPR approaches for functional studies of long non-coding RNA
Awwad, D. A. (2019) · Biology Methods and Protocols · doi:10.1093/biomethods/bpz017 · Cited by 28
Dna2 initiates resection at clean DNA double-strand breaks
Paudyal, S. C., Li, S., Yan, H., Hunter, T. R., & You, Z. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx830 · Cited by 30
HMEJ-mediated efficient site-specific gene integration in chicken cells
Xie, L., Sun, J., Mo, L., Xu, T., Shahzad, Q., Chen, D., Yang, W., Liao, Y., & Lu, Y. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0217-9 · Cited by 26
Therapeutic genome engineering via CRISPR ‐Cas systems
Moreno, A. M., & Mali, P. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1380 · Cited by 25
RNA-Guided Recombinase-Cas9 Fusion Targets Genomic DNA Deletion and Integration
Standage-Beier, K., Brookhouser, N., Balachandran, P., Zhang, Q., Brafman, D. A., & Wang, X. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.0013 · Cited by 26
van den Berk, P. C. M., Lancini, C., Serresi, M., Sánchez-Bailón, M. P., Hulsman, D., Pritchard, C., Song, J., Schmitt, M. J., Tanger, E., Popp, O., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108533 · Cited by 25
Function and Evolution of the Loop Extrusion Machinery in Animals
Kabirova, E., Nurislamov, A. R., Shadskiy, A., Smirnov, A. V., Popov, A., Salnikov, P., Баттулин, Н. Р., & Fishman, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24055017 · Cited by 27
Gene editing innovations and their applications in cardiomyopathy research
Kyriakopoulou, E., Monnikhof, T., & van Rooij, E. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050088 · Cited by 26
Hayes, J. D., & Dinkova‐Kostova, A. T. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.009 · Cited by 25
Tsukamoto, T., Sakai, E., Iizuka, S., Taracena-Gándara, M., Sakurai, F., & Mizuguchi, H. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00222 · Cited by 25
Song, F., Li, M., Liu, G., Swapna, G. V. T., Daigham, N. S., Xia, B., Montelione, G. T., & Bunting, S. F. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00789 · Cited by 25
Self-citationEvolution of Resistance in Cancer: A Cell Cycle Perspective
Dökümcü, K., & Farahani, R. H. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00376 · Cited by 26
Role of deubiquitinating enzymes in DNA double-strand break repair
Li, Y., & Yuan, J. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000309 · Cited by 25
Tracing back primed resistance in cancer via sister cells
Dai, J., Zheng, S., Falco, M. M., Bao, J., Eriksson, J., Pikkusaari, S., Forstén, S., Jiang, J., Wang, W., Gao, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45478-7 · Cited by 24
Fuentes, C., & Schaffer, D. V. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2018.08.003 · Cited by 27
Controlling DNA-End Resection: An Emerging Task for Ubiquitin and SUMO
Himmels, S.-F., & Sartori, A. A. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00152 · Cited by 24
Enikanolaiye, A., Ruston, J., Zeng, R., Taylor, C., Schrock, M., Buchovecky, C. M., Shendure, J., Acar, E. F., & Justice, M. J. (2020) · Genome Research · doi:10.1101/gr.258400.119 · Cited by 25
Ubiquitylation in DNA double-strand break repair
Tang, M., Li, S., & Chen, J. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103129 · Cited by 24
Making Connections: Integrative Signaling Mechanisms Coordinate DNA Break Repair in Chromatin
Sanchez, A. R., Lee, D., Kim, D. I., & Miller, K. M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.747734 · Cited by 25
Future Directions for Adrenal Insufficiency: Cellular Transplantation and Genetic Therapies
Graves, L. E., Torpy, D. J., Coates, P. T., Alexander, I. E., Bornstein, S. R., & Clarke, B. M. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac751 · Cited by 23
Role of PRMT1 and PRMT5 in Breast Cancer
Martinez, S., Sentis, S., Poulard, C., Trédan, O., & Romancer, M. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168854 · Cited by 25
Deveryshetty, J., Ryzhikov, M., Brahati, N., Peterlini, T., Dellaire, G., Masson, J., & Korolev, S. (2019) · eLife · doi:10.7554/elife.44063 · Cited by 22
Self-citationGarvin, A. J. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190534 · Cited by 25
RNF8 has both KU-dependent and independent roles in chromosomal break repair
Tsai, L. J., Lopezcolorado, F. W., Bhargava, R., Mendez‐Dorantes, C., Jahanshir, E., & Stark, J. M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa380 · Cited by 23
Cao, Y., Xiong, J., Li, Z., Zhang, G., Tu, Y., Wang, L., & Jie, Z. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10624 · Cited by 21
Attwood, K. M., Salsman, J., Chung, D., Mathavarajah, S., Iderstine, C. V., & Dellaire, G. (2019) · Biochemistry and Cell Biology · doi:10.1139/bcb-2019-0115 · Cited by 20
Self-citationUbiquitin-Regulated Cell Proliferation and Cancer
Pérez‐Benavente, B., Fathinajafabadi, A., & Farrás, R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_1 · Cited by 21
KEAP1-NRF2 Interaction in Cancer: Competitive Interactors and Their Role in Carcinogenesis
Oskomić, M., Tomić, A., Barbarić, L., Matić, A., Kindl, D. C., & Matovina, M. (2025) · Cancers · doi:10.3390/cancers17030447 · Cited by 22
Gene editing and CRISPR-dependent homology-mediated end joining
Ruis, B. L., Bielinsky, A., & Hendrickson, E. A. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01442-z · Cited by 20
Regulatory mechanism of cyclins and cyclin-dependent kinases in post-mitotic neuronal cell division
Gupta, R. V., Jha, A., Ambasta, R. K., & Kumar, P. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120006 · Cited by 19
BRCA2 BRC missense variants disrupt RAD51-dependent DNA repair
Jiménez-Sáinz, J., Mathew, J., Moore, G., Lahiri, S., Garbarino, J. M., Eder, J. P., Rothenberg, E., & Jensen, R. B. (2022) · eLife · doi:10.7554/elife.79183 · Cited by 19
A homology independent sequence replacement strategy in human cells using a CRISPR nuclease
Danner, E. W., Lebedin, M. Y., de la Rosa, K., & Kühn, R. (2021) · Open Biology · doi:10.1098/rsob.200283 · Cited by 22
Protein UFMylation regulates early events during ribosomal DNA-damage response
Panichnantakul, P., Aguilar, L. C., Daynard, E., Guest, M., Peters, C., Vogel, J., & Oeffinger, M. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114738 · Cited by 18
Ubiquitylation-Mediated Fine-Tuning of DNA Double-Strand Break Repair
Borsos, B. N., Majoros, H., & Pankotai, T. (2020) · Cancers · doi:10.3390/cancers12061617 · Cited by 18
Kumar, S., Zhao, J., Talluri, S., Buon, L., Mu, S., Potluri, L. B., Liao, C., Shi, J., Chakraborty, C., Gonzalez, G. B., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.04.035 · Cited by 18
BLM and BRCA1-BARD1 coordinate complementary mechanisms of joint DNA molecule resolution
Tsukada, K., Jones, S. E., Bannister, J. V., Durin, M.-A., Vendrell, I., Fawkes, M., Fischer, R., Kessler, B. M., Chapman, J. R., & Blackford, A. N. (2024) · Molecular Cell · doi:10.1016/j.molcel.2023.12.040 · Cited by 18
Platinum-based chemotherapy: trends in organic nanodelivery systems
Santos, J. A. V., Silva, D., Marques, M. P. M., & de Carvalho, L. A. E. B. (2024) · Nanoscale · doi:10.1039/d4nr01483a · Cited by 20
Regulation of DNA break repair by transcription and RNA
Ouyang, J., Lan, L., & Zou, L. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9164-1 · Cited by 18
Cathepsin B contributes to radioresistance by enhancing homologous recombination in glioblastoma
Zhang, X., Wang, X., Xu, S., Li, X., & Ma, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.007 · Cited by 18
The roles of homologous recombination and the immune system in the genomic evolution of cancer
Nandi, B., Talluri, S., Kumar, S., Yenumula, C., Gold, J. S., PRABHALA, R. H., Munshi, N. C., & Shammas, M. A. (2018) · Journal of Translational Science · doi:10.15761/jts.1000282 · Cited by 18
The internal region of CtIP negatively regulates DNA end resection
Howard, S. M., Ceppi, I., Anand, R., Geiger, R., & Ćejka, P. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa273 · Cited by 19
Chromatin Ubiquitination Guides DNA Double Strand Break Signaling and Repair
Kolobynina, K. G., Rapp, A. W., & Cardoso, M. C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.928113 · Cited by 17
Rice OsBRCA2 Is Required for DNA Double-Strand Break Repair in Meiotic Cells
Fu, R., Wang, C., Shen, H., Zhang, J., Higgins, J. D., & Liang, W. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.600820 · Cited by 17
Gene Therapy: The View from NCATS
Brooks, P. J., Yang, N. N., & Austin, C. P. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.29018.pjb · Cited by 16
Scorpins in the DNA Damage Response
Palmieri, D., Tessari, A., & Coppola, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061794 · Cited by 16
DNA-dependent protein kinase: Epigenetic alterations and the role in genomic stability of cancer
Vazhappilly, C. G., Ansari, S. A., Chelakkot, V. S., Chelakkot, A. L., Chelakkot, C., Menon, V., Ramadan, W. S. H., Radhakrishnan, E. K., El‐Awady, R., Mantso, T., et al. (2018) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2018.06.001 · Cited by 16
Self-citationGoshayeshi, L., Taemeh, S. Y., Dehdilani, N., Nasiri, M., Seno, M. M. G., & Dehghani, H. (2021) · The FASEB Journal · doi:10.1096/fj.202001830rr · Cited by 16
Eini, O., Schumann, N., Niessen, M., & Varrelmann, M. (2021) · New Biotechnology · doi:10.1016/j.nbt.2021.12.002 · Cited by 16
Jin, Q., Gutierrez-Diaz, B. T., Pieters, T., Zhou, Y., Narang, S., Fijałkowski, I., Borin, C., Laere, J. V., Payton, M. A., Cho, B.-K., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq8437 · Cited by 16
miR4673 improves fitness profile of neoplastic cells by induction of autophagy
Dökümcü, K., Simonian, M. R., & Farahani, R. H. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1088-6 · Cited by 16
Boonen, R. A. C. M., Vreeswijk, M. P. G., & van Attikum, H. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00169 · Cited by 18
Dowaidar, M. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/3nwzd · Cited by 22
Crist, C. G. (2016) · The Journal of Pathology · doi:10.1002/path.4830 · Cited by 15
Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
Padmaswari, M. H., Agrawal, S., Jia, M. S., Ivy, A., Maxenberger, D. A., Burcham, L. A., & Nelson, C. E. (2023) · Biophysics Reviews · doi:10.1063/5.0131452 · Cited by 18
Keeping homologous recombination in check
Fugger, K., & West, S. C. (2016) · Cell Research · doi:10.1038/cr.2016.25 · Cited by 15
Protein kinase C activator bryostatin‐1 modulates proteasome function
Khan, T. K., & Nelson, T. J. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26887 · Cited by 15
Duplex Labeling and Manipulation of Neuronal Proteins Using Sequential CRISPR/Cas9 Gene Editing
Droogers, W. J., Willems, J., MacGillavry, H. D., & de Jong, A. P. H. (2022) · eNeuro · doi:10.1523/eneuro.0056-22.2022 · Cited by 17
Mitotic cells can repair DNA double-strand breaks via a homology-directed pathway
Sakamoto, Y., Kokuta, T., Teshigahara, A., Iijima, K., Kitao, H., Takata, M., & Tauchi, H. (2020) · Journal of Radiation Research · doi:10.1093/jrr/rraa095 · Cited by 15
Metadata
- Authors
- Orthwein, A., Noordermeer, S. M., Wilson, M. D., Landry, S., Enchev, R. I., Sherker, A., Munro, M., Pinder, J., Salsman, J., Dellaire, G., Xia, B., Peter, M., & Durocher, D.
- Affiliations
- Mount Sinai Hospital (CA)
- ETH Zurich (CH)
- Dalhousie University (CA)
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Durocher, Daniel
- ORCID
- Venue
- Nature
- Published
- 2015-12-09
- Volume
- 528
- Issue
- 7582
- Pages
- 422-426
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4880051
- OpenAlex
- W2202899490
- Cited by
- 471
- References
- 39
- Citations by year
- 2026: 4 · 2025: 17 · 2024: 26 · 2023: 35 · 2022: 36 · 2021: 52 · 2020: 61 · 2019: 64 · 2018: 52 · 2017: 67 · 2016: 54 · 2015: 1
- FWCI
- 25.17
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- retraction (2025-01-27)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Centers for Disease Control and Prevention
- Canadian Institutes of Health Research (FDN143343 (, MOP84260)
- National Cancer Institute (R01CA138804)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- homologous recombination, G1 cell cycle, BRCA1, PALB2, BRCA2, DNA end resection, cell cycle regulation, Keap1, CUL3, RBX1, USP11, ubiquitination, sister chromatid recombination, DNA repair, CRISPR/Cas9
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Fanconi Anemia Complementation Group N Protein, Amino Acid Sequence, Carrier Proteins, Cell Line, DNA, DNA Damage, DNA Repair, Humans, Molecular Sequence Data, Nuclear Proteins, Protein Binding, Thiolester Hydrolases, G1 Phase, G2 Phase, S Phase, Gene Targeting, BRCA1 Protein, BRCA2 Protein, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Cullin Proteins, Multiprotein Complexes, Intracellular Signaling Peptides and Proteins, Rad51 Recombinase, Ubiquitination, Homologous Recombination, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review